| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |